Intellia Therapeutics (NASDAQ:NTLA) Price Target Cut to $60.00 by Analysts at Chardan Capital
Intellia Therapeutics (NASDAQ:NTLA – Get Free Report) had its price objective decreased by equities research analysts at Chardan Capital from $68.00 to $60.00 in a...
Lyft’s (LYFT) Neutral Rating Reaffirmed at Susquehanna
Lyft (NASDAQ:LYFT – Get Free Report)‘s stock had its “neutral” rating reissued by investment analysts at Susquehanna in a note issued to investors on Monday,...
Innoviva (NASDAQ:INVA) Now Covered by Analysts at Oppenheimer
Stock analysts at Oppenheimer began coverage on shares of Innoviva (NASDAQ:INVA – Get Free Report) in a research report issued to clients and investors on...
Jefferies Financial Group Has Lowered Expectations for MarketAxess (NASDAQ:MKTX) Stock Price
MarketAxess (NASDAQ:MKTX – Get Free Report) had its price objective reduced by equities researchers at Jefferies Financial Group from $217.00 to $208.00 in a report...
Pagaya Technologies (NASDAQ:PGY) Given New $36.00 Price Target at Canaccord Genuity Group
Pagaya Technologies (NASDAQ:PGY – Get Free Report) had its price objective increased by stock analysts at Canaccord Genuity Group from $28.00 to $36.00 in a...
Wells Fargo & Company Lowers Lamar Advertising (NASDAQ:LAMR) Price Target to $119.00
Lamar Advertising (NASDAQ:LAMR – Get Free Report) had its target price reduced by research analysts at Wells Fargo & Company from $122.00 to $119.00 in...